Additionally, the marked upregulation of platelet factor 4 (> 4-fold) signifies risk for thromboembolic events as seen in clinical cases, and owing to its role in coronary artery disease and myocardial infarction, the highly significant repression of the phosphatase and actin regulator is another remarkable finding [57]. The gene discussed is PF4; the disease is myocardial infarction.